1. Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from the Spanish group GELTAMO. (June 2017) Authors: Martín, A.; Baile, M.; Rodríguez, G.; Dlouhy, I.; Sancho, J.M.; Jarque, I.; González‐Barca, E.; Salar, A.; Espeso, M.; Grande, C.; Bergua, J.; Montes‐Moreno, S.; López‐Guillermo, A.; Campo, E.; Caballero, D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1702: IMPACT OF CENTER CHARACTERISTICS AND MACROECONOMIC FACTORS ON THE OUTCOME OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED PROTOCOLS. (23rd June 2022) Authors: Barba, P.; Morgades, M.; Montesinos, P.; Gonzalez Campos, J.; Torrent, A.; Gil, C.; Bernal, T.; Tormo, M.; Mercadal, S.; Saumell, S.; García-Cadenas, I.; Queipo de Llano, M.; Cervera, M.; Coll, R.; Bermudez, A.; Amigo, M.; Monsalvo, S.; Esteve, J.; Garcia Boyero, R.; Novo, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗